Israeli agency to produce vaccine for COVID-19 in 8-10 weeks

Kiryat Shmona: Israeli researchers at Migal-Galilee Research Institute have announced that they have achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against Coronavirus in the coming weeks.

The institute announced the development of a vaccine against avian coronavirus Infectious Bronchitis Virus (IBV) and are adapting it to create a human vaccine against coronavirus (COVID-19), which is rapidly spreading across the world.

Commenting on the report, David Zigdon, CEO of Migal Galilee Research Institute, said, “Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks and to achieve safety approval in 90 days. This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion of final product development and regulatory activities.”

According to a statement, the Migal-Galilee Research Institute has announced that after four years of multi-disciplinary research funded by Israel’s Ministry of Science and Technology in cooperation with Israel’s Ministry of Agriculture, the research institute has achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against coronavirus.

Israel’s Minister of Science and Technology, Ofir Akunis, commented: “Congratulations to MIGAL on this exciting breakthrough. I am confident that there will be further rapid progress, enabling us to provide a needed response to the grave global COVID-19 threat.”

Akunis has instructed the Director-General of the Ministry of Science and Technology to fast-track all approval processes with the goal of bringing the human vaccine to market as quickly as possible.

This possibility was identified as a by-product of MIGAL’s development of a vaccine against IBV (Infectious Bronchitis Virus), a disease affecting poultry, whose effectiveness has been proven in pre-clinical trials carried out at the Volcani Institute. (IANS)

Also Read: Israeli PM Benjamin Netanyahu wins in Likud party leadership primary election

Also Watch: Fans of Zubeen Garg prays for his early recovery in Gohpur, Watch here